Niagen Bioscience delivered a solid fourth quarter with a 16% increase in net sales, driven primarily by strong e-commerce growth for Tru Niagen®. While net income decreased compared to the prior year due to one-time benefits in 2024, the company achieved record full-year revenue and significantly strengthened its cash position and intellectual property portfolio.